|
Mon, 03/24/2025 - 22:51 |
New Non-Surgical Contraceptive Implant is Delivered Through Tiny Needles |
Mass General Brigham |
|
Tue, 08/27/2024 - 20:25 |
Fresenius Kabi Expands Womens Health Portfolio with New Generic Option for Reproductive Health |
Fresenius Kabi |
|
Wed, 11/09/2022 - 23:19 |
Otsuka Announces the Launch in Japan of Auto-Injector Dosage Form for AJOVY Subcutaneous Injection 225mg for Preventive Treatment of Migraine |
Otsuka |
|
Tue, 10/18/2022 - 13:44 |
PDA Announces 2022 Drug Delivery Innovation Awards Winners |
Parenteral Drug... |
|
Thu, 08/25/2022 - 05:25 |
TPPF Applauds Governor Newsoms Veto of Safe Injection Sites |
Texas Policy |
|
Thu, 08/11/2022 - 13:08 |
Kaleo Announces Executive Appointments and New Government Business Unit |
Kaleo |
|
Fri, 08/05/2022 - 11:44 |
MHRA and CAP take action against illegal hay fever injection adverts online |
Allergy UK |
|
Thu, 01/20/2022 - 06:40 |
OEDIT to attend Arab Health 2022 |
Colorado OEDIT |
|
Wed, 11/10/2021 - 21:23 |
Independent dermatology research experts at Monasterium Laboratory GmbH will test, analyze and validate various injection parameters using donated human tissue |
RepliCel |
|
Thu, 10/28/2021 - 14:38 |
RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line |
RepliCel |
|
Tue, 10/12/2021 - 03:53 |
New Research Shows Neighborhood Safe Consumption Sites Reduce Improper Syringe Disposal in Public Spaces |
RTI International |
|
Sat, 06/26/2021 - 07:46 |
FDA Accepts Braeburns New Drug Application Resubmission for BRIXADI (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder |
Braeburn Pharma... |
|
Tue, 06/15/2021 - 00:40 |
Braeburn Resubmits New Drug Application for BRIXADI (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder |
Braeburn Pharma... |
|
Fri, 05/21/2021 - 19:14 |
Temsirolimus Injection Now Available from Fresenius Kabi |
Fresenius Kabi |
|
Mon, 03/22/2021 - 19:12 |
EISAI BEGINS CONSTRUCTION OF ITS NEW INJECTION/RESEARCH BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN |
EISAI |
|
Mon, 01/25/2021 - 16:57 |
Velanos Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of Practice |
Velano Vascular |
|
Mon, 01/04/2021 - 06:06 |
ASAM Submits Comment Letter to the DEA on the Implementation of the SUPPORT Act of 2018 |
ASAM |
|
Tue, 12/01/2020 - 07:26 |
Fresenius Kabi Launches Icatibant Injection to Treat Acute Attacks of Hereditary Angioedema in Adults |
Fresenius Kabi |
|
Mon, 09/07/2020 - 20:54 |
Enable Injections Announces $25 Million Credit Facility Closed with Oxford Finance |
Oxford Finance |
|
Fri, 08/28/2020 - 00:32 |
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up |
Viatris |
|
Wed, 08/26/2020 - 22:37 |
Supervised consumption bill AB 362 stalls; Critical need for overdose prevention services continues |
SFAF |
|
Thu, 07/09/2020 - 03:31 |
DPA Submits Amicus Brief Cosigned by AMA Supporting Attempt to Establish Supervised Consumption Site in Philadelphia |
Drug Policy Alliance |
|
Tue, 06/23/2020 - 19:01 |
Fresenius Kabi Expands MicroVault Packaging to include Simplist Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes |
Fresenius Kabi |
|
Mon, 04/27/2020 - 11:38 |
Teva Announces U.S. Launch of Autoinjector for AJOVY (fremanezumab-vfrm) Injection |
Teva Pharmaceutical |
|
Tue, 03/17/2020 - 09:03 |
Epinephrine Nasal Spray Demonstrates Bioequivalent Exposure and Absorption Rate Compared to Epinephrine Injectors |
AAAAI |
